Notice: This company has been marked as potentially delisted and may not be actively trading. Edge Therapeutics (EDGE) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsHeadlinesTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Forecasting The Future: 9 Analyst Projections For Capricor TherapeuticsOctober 9 at 7:20 PM | benzinga.comCity Therapeutics launches with $135m Series A fundingOctober 9 at 7:20 PM | msn.comAfter Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's StudyOctober 8 at 11:05 AM | uk.finance.yahoo.comBayer and MOMA Therapeutics Enter Collaboration and License Agreement in OncologyOctober 8 at 11:05 AM | finance.yahoo.comAnalyst Scoreboard: 12 Ratings For Sarepta TherapeuticsOctober 4, 2024 | benzinga.comEliem Therapeutics Changes Name to Climb BioOctober 3, 2024 | finance.yahoo.comCamp4 Therapeutics Targets IPO On Early Positive ResultsOctober 1, 2024 | seekingalpha.comSPIMA Therapeutics Launches to Transform Peptide-Based Immunotherapies and Announces Global Licensing Agreement with SATT AxLRSeptember 30, 2024 | finance.yahoo.comModalis Therapeutics: FDA Grants Rare Pediatric Disease Designation to MDL-101 for the Treatment of Congenital Muscular Dystrophy Type 1a (LAMA2-CMD)September 30, 2024 | finance.yahoo.comIs Sarepta Therapeutics, Inc. (SRPT) One of the Best Revenue Growth Stocks to Buy According to Analysts?September 30, 2024 | msn.comThe Analyst Landscape: 7 Takes On Kymera TherapeuticsSeptember 27, 2024 | benzinga.comStock Market Today: Stocks edge lower with PCE inflation data on deckSeptember 27, 2024 | finance.yahoo.comA Closer Look at 10 Analyst Recommendations For Celldex TherapeuticsSeptember 25, 2024 | benzinga.comSage Therapeutics, Inc. (SAGE) Hits 52-Week Lows After Trial Failures, According to Short SellersSeptember 25, 2024 | msn.comViking Therapeutics Unusual Options Activity For September 24September 24, 2024 | benzinga.comBuy Rating for Structure Therapeutics: GSBR-1290’s Market Potential in DiabesitySeptember 24, 2024 | markets.businessinsider.comNona Biosciences Enters Strategic Collaboration with Alkyon Therapeutics for Next-Generation Immunotherapeutics DiscoverySeptember 24, 2024 | finance.yahoo.comRyvu Therapeutics to present ONCO Prime platform at the 6th Annual RAS-Targeted Drug Development SummitSeptember 23, 2024 | finance.yahoo.comLarimar Therapeutics to Present Groundbreaking Nomlabofusp Studies at ICAR ConferenceSeptember 21, 2024 | msn.comDeep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings)September 21, 2024 | benzinga.comGC Therapeutics Launches to Scale and Unlock the Next Generation of Cell TherapySeptember 19, 2024 | businesswire.comFlashpoint Therapeutics Scientific Founder, Chad Mirkin, Receives 2024 Kavli Prize for Groundbreaking Work on Spherical Nucleic AcidsSeptember 19, 2024 | finance.yahoo.comHow Edgewise, Up 55%, Is Hoping To Edge Out Bristol, Cytokinetics In Heart DiseaseSeptember 19, 2024 | msn.comJones Trading Initiates Coverage of Beam Therapeutics (BEAM) with Hold RecommendationSeptember 19, 2024 | msn.comAsimov Launches AAV Edge, a Suite of AI Models, Host Cells, and Genetic Tools for End-to-End Gene Therapy DevelopmentSeptember 18, 2024 | finance.yahoo.comME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics CollaborationSeptember 18, 2024 | finance.yahoo.comMirador Therapeutics Appoints Gregg Gilbert at Chief Financial OfficerSeptember 17, 2024 | tmcnet.comIVIEW Therapeutics Inc. Completes Patient Recruitment for Phase 1/2 Trial of IVW-1001 Ophthalmic Eyelid Wipe in Dry Eye Disease PatientsSeptember 17, 2024 | finance.yahoo.comWhat the Options Market Tells Us About Viking TherapeuticsSeptember 17, 2024 | benzinga.comHEST Investments Leads $1.8 Million SPV Investment in Secretome Therapeutics to Advance Human TrialsSeptember 17, 2024 | finance.yahoo.comBuy Rating on Viking Therapeutics: Superior Safety Profile and Market Potential in Obesity TreatmentSeptember 16, 2024 | markets.businessinsider.comBuy Rating for Cartesian Therapeutics: Promising Clinical Trials and Innovative mRNA CAR T Cell TherapySeptember 16, 2024 | markets.businessinsider.comCarisma Therapeutics and Moderna Expand Partnership to Target Autoimmune DiseasesSeptember 15, 2024 | msn.comVariscite and Peridio Partner to Accelerate Development of Edge AI DevicesSeptember 10, 2024 | tmcnet.comAffinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial OfficerSeptember 10, 2024 | finance.yahoo.comState’s big move on cutting-edge vaccinesSeptember 8, 2024 | msn.comCMP Scientific's Cutting-Edge Technology Solves CE-SDS Peak Identification ChallengeSeptember 6, 2024 | finance.yahoo.comJefferies Initiates Coverage of Amicus Therapeutics (FOLD) with Buy RecommendationSeptember 6, 2024 | msn.comPeptide Therapeutics Market Size is Expected to Reach USD 85.9 billion, Advancing at a CAGR of 9.6% by 2031: Transparency Market Research Inc.September 4, 2024 | finance.yahoo.comSkyline Therapeutics' Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis PigmentosaSeptember 4, 2024 | finance.yahoo.comPensar Medical Partners with Centurion Therapeutics for Innovative Negative Pressure Wound Therapy SystemAugust 30, 2024 | finance.yahoo.comEuropean Equities Traded in the US as American Depositary Receipts Edge Lower Friday; Set to End Week Up 0.5%August 30, 2024 | msn.comMyeloid Therapeutics to Participate in Upcoming Investor ConferencesAugust 29, 2024 | finance.yahoo.comArcturus Therapeutics: A Strong Buy on Promising Vaccine Developments and Strategic CollaborationsAugust 27, 2024 | markets.businessinsider.comBicara Therapeutics Plans $200 Million IPO For Head & Neck Cancer DrugAugust 27, 2024 | seekingalpha.comYolTech Therapeutics Administers First Patient Dose in IIT of YOLT-203, the World's First In Vivo Gene Editing Therapy for PH1August 24, 2024 | finance.yahoo.comEuropean Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday TradingAugust 20, 2024 | msn.comDenali Therapeutics: A Promising Biotech With Revolutionary BBB-Crossing TechnologyAugust 20, 2024 | seekingalpha.comIterum Therapeutics plc (NASDAQ:ITRM) Q2 2024 Earnings Call TranscriptAugust 17, 2024 | msn.comCrown Laboratories, Inc.: Crown Laboratories and Revance Announce Entry Into Merger AgreementAugust 15, 2024 | finanznachrichten.de Get Edge Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EDGE and its competitors with MarketBeat's FREE daily newsletter. Email Address War on Elon Escalates… (Ad)Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. Click here to learn how you can benefit from its widespread distribution. EDGE Media Mentions By Week EDGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EDGE News Sentiment▼0.000.72▲Average Medical News Sentiment EDGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EDGE Articles This Week▼55▲EDGE Articles Average Week Get Edge Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EDGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aquestive Therapeutics News Today Erasca News Today Altimmune News Today CorMedix News Today Sage Therapeutics News Today Emergent BioSolutions News Today Xeris Biopharma News Today COMPASS Pathways News Today Verve Therapeutics News Today Cryoport News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EDGE) was last updated on 10/11/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edge Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edge Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
